Search research articles
Contact Us
Filters
Showing results (141-150 of 272) with videos related to
Page
of 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2018
Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
Christian Menzer, Bernd Beedgen, Joachim Rom, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2014
Comparison of molecular abnormalities in vulvar and vaginal melanomas
Sebastian Aulmann, Hans P Sinn, Roland Penzel, et al.
ESMO Open
|
June 25, 2019
Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management
Lucie Heinzerling, Thomas K Eigentler, Michael Fluck, et al.
Cancers
|
July 14, 2023
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition
Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2022
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Martin Salzmann, Johannes Pawlowski, Carmen Loquai, et al.
Cancers
|
June 13, 2025
Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors
Lisa Arnold, Monika Morak, Nora Kramer, et al.
Cancers
|
December 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. <i>Cancers</i> 2023, <i>15</i>, 3448
Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Trials
|
April 21, 2021
Development and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial
Pia Grabbe, Kathrin M Gschwendtner, Imad Maatouk, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
Simone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 18, 2025
Monitoring soluble cMET and ctDNA in metastatic uveal melanoma patients to track early disease progression on immunotherapies
Devayani Machiraju, Christian H Ziener, Elena Clementi, et al.
Page
of 28
Search research articles
Search
Showing results (141-150 of 272) with videos related to
Sort By:
Page
of 28
European Journal of Cancer (Oxford, England : 1990)
|
November 21, 2018
Immunotherapy with ipilimumab plus nivolumab in a stage IV melanoma patient during pregnancy
Christian Menzer, Bernd Beedgen, Joachim Rom, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
March 8, 2014
Comparison of molecular abnormalities in vulvar and vaginal melanomas
Sebastian Aulmann, Hans P Sinn, Roland Penzel, et al.
ESMO Open
|
June 25, 2019
Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management
Lucie Heinzerling, Thomas K Eigentler, Michael Fluck, et al.
Cancers
|
July 14, 2023
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition
Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 10, 2022
MEK inhibitors for pre-treated, NRAS-mutated metastatic melanoma: A multi-centre, retrospective study
Martin Salzmann, Johannes Pawlowski, Carmen Loquai, et al.
Cancers
|
June 13, 2025
Interleukin-4 and -13 Gene Expression Profiles in Immune-Related Bullous Pemphigoid Indicate Efficacy of IL-4/IL-13 Inhibitors
Lisa Arnold, Monika Morak, Nora Kramer, et al.
Cancers
|
December 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. <i>Cancers</i> 2023, <i>15</i>, 3448
Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Trials
|
April 21, 2021
Development and validation of a web-based patient decision aid for immunotherapy for patients with metastatic melanoma: study protocol for a multicenter randomized trial
Pia Grabbe, Kathrin M Gschwendtner, Imad Maatouk, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2013
Upstream mitogen-activated protein kinase (MAPK) pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients
Simone M Goldinger, Lisa Zimmer, Carsten Schulz, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
July 18, 2025
Monitoring soluble cMET and ctDNA in metastatic uveal melanoma patients to track early disease progression on immunotherapies
Devayani Machiraju, Christian H Ziener, Elena Clementi, et al.
Page
of 28